Skip to main content
. 2024 Mar 14;29(6):527–533. doi: 10.1093/oncolo/oyae035

Table 3.

Unadjusted and weighted prevalence of high versus low-price treatment, by insurance type.

Unadjusted Weighted
n HP treatment LP treatment HP treatment LP treatment
Overall, n (%) 812 272 (33.5) 540 (66.5) 276.0 (33.9) 537.1 (66.1)
Insurance type, n (%)
 Commercial 603 215 (35.7) 388 (64.3) 206.5 (35.3) 379.0 (64.7)
 Medicaid 209 57 (27.3) 152 (72.7) 69.5 (30.5) 158.1 (69.5)

Abbreviations: HP, high price; LP, low cost.